|
|
|
| Epidemiological characteristics of coronavirus disease 2019 in Huzhou |
| JIN Meihua*, SHEN Jianyong, FU Yun, LIU Guangtao, LIU Yan, YANG Zhongrong, REN Feilin, XU Deshun, CHEN Liqiang, ZOU Yong, DONG Xiaolian, SHAO Bin, LIU Bin
|
| Huzhou Center for Disease Control and Prevention,Huzhou,Zhejiang 313000,China |
|
|
|
|
Abstract Objective To learn the epidemiological characteristics of coronavirus disease 2019（COVID-19）in Huzhou,so as to provide reference for prevention and control of COVID-19. Methods All the confirmed cases of COVID-19 in Huzhou,diagnosed according to the COVID-19 Diagnosis and Treatment Plan（Sixth Version Trial）and reported from January 25 to February 7,2020,were recruited. The process of diagnosis and treatment,clinical manifestation,exposure history and close contacts were collected to analyze the epidemiological characteristics. Results On January 25,the first confirmed cases of COVID-19 in Huzhou was reported. By February 7,totally 10 confirmed cases were reported and no asymptomatic infection was found. They were all imported,including three Wuhan residents,two with a trip to Wuhan,three with a trip to Suizhou,one with a trip to Hangzhou and one with a trip to Thailand（two Wuhan passengers on the same flight）. The ratio of male to female cases was 1∶1. The median age was 32 years old. Seven cases were found when they went to a doctor by themselves,and three cases were found during the quarantine. The main clinical manifestations were fever,dry cough and fatigue. The median time from onset to diagnosis was 3 days. By March 3,all the cases were discharged,with median course of 24 days. There were 312 close contacts,and all of them were released after 14 days of quarantine. Conclusions To prevent imported cases from outside and stop spread inside taken by Huzhou government was proved to be effective. All the COVID-19 cases in Huzhou were imported,mostly from Wuhan. No local cases were reported.
|
|
Received: 08 March 2020
Revised: 26 March 2020
Published: 12 May 2020
|
|
|
|
|
|
[1] JI J S.Origins of MERS-CoV,and lessons for 2019-nCoV[J]. Lancet Planet Health,2020,4(3):e93.
[2] Emerging understandingsof 2019-nCoV[J]. Lancet, 2020, 395(10221):311.
[3] ZHAO S, LIN Q, RAN J, et al.Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020:A data-driven analysis in the early phase of the outbreak[J]. Int J Infect Dis,2020(92):214-217. [4] CHAN J F, KOK K H, ZHU Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan [J]. Emerg Microbes Infect, 2020, 9(1):221-236.
[5] ZHU N, ZHANG D, WANG W, et al.A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med,2020,382(8):727-733.
[6] 林君芬, 吴梦娜, 吴昊澄,等. 浙江省新型冠状病毒肺炎病例流行特征分析[J]. 预防医学, 2020,32(3):217-221,225.
[7] 中华人民共和国国家卫生健康委办公厅.关于印发《新型冠状病毒肺炎诊疗方案(试行第六版)》的通知[EB/OL].(2020-02-18)[2020-03-26]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml from=timeline.
[8] 中华人民共和国国家卫生健康委员会. 国家卫生健康委办公厅关于印发《新型冠状病毒感染的肺炎防控方案(第三版)》的通知[EB/OL].(2020-01-28)[2020-03-26]. http://www.gov.cn/zhengce/zhengceku/2020-01/29/content_5472893.htm.
[9] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志,2020,41(2):145-151.
[10] ZHANG J J, DONG X, CAO Y Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan,China [J]. Allergy,2020[2020-03-26]. https://www.ncbi.nlm.nih.gov/pubmed/32077115 .DOI:10.1111/all.14238.
[11] YANG W, CAO Q, QIN L, et al.Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China[J]. J Infect,2020,80(4):388-393.
[12] KOORAKI S, HOSSEINY M, MYERS L,et al. Coronavirus (COVID-19) outbreak: what the department of radiology should know [J]. J Am Coll Radiol,2020[2020-03-26]. https://www.ncbi.nlm.nih.gov/pubmed/ term=Coronavirus+(COVID-19)+Outbreak%3A+What+the+Department+of+Radiology+Should+Know.DOI:10.1016/j.jacr.2020.02.008.
[13] 房晓伟,梅清,杨田军,等.2019新型冠状病毒感染的肺炎79例临床特征及治疗分析[J].中国药理学通报,2020[2020-03-26]. 2019新型冠状病毒感染的肺炎79例临床特征及治疗分析[J].中国药理学通报,2020[2020-03-26]. http://kns.cnki.net/kcms/detail/34.1086.r.20200224.1340.002.html.DOI:10.3969/j.issn.1001-1978.2020.
[14] 杨静,解超英,阳成英.新型冠状病毒肺炎普通型病例40例临床研究[J].实用心脑肺血管病杂志,2020,28(2):1-4.
[15] 唐安, 仝振东, 李科峰,等. 舟山市新型冠状病毒肺炎病例流行病学特征分析[J].预防医学,2020,32(2):113-116.
[16] World Health Organization. Coronavirus disease2019(COVID-19)Situation Report-37 [EB/OL].(2020-02-26)[2020-03-26].https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200226sitrep-37-covid-19.pdf?sfvrsn=2146841e_2.
[17] KAPATA N, IHEKWEAZU C, NTOUMI F, et al.Is the Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic - lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future[J]. Int J Infect Dis,2020(93):233-236.
[18] LILLIE P J, SAMSON A, LI A, et al. Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission[J]. J Infect,2020[2020-03-26]. https://www.ncbi.nlm.nih.gov/pubmed/ term=Novel+coronavirus+disease+(Covid-19 )%3A+the+first+two+patients+in+the+UK+with+person+to+person+transmission.DOI:10.1016/j.jinf.2020.02.020.
[19] SPINA S, MARRAZZO F, MIGLIARI M, et al.The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy[J]. Lancet, 2020,395(10227):e49-e50.
[20] PAN X F, CHEN D X, XIA Y, et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection [J]. Lancet Inf Dis,2020[2020-03-26].https://pubmed.ncbi.nlm.nih.gov/32087116/.DOI: 10.1016/S1473-3099(20)30114-6. |
|
|
|
